1/13/2020 7:48:29 AM
Biogen Agrees To Acquire PF-05251749 From Pfizer
12/13/2019 7:40:26 AM
Biogen: Primary Endpoint Of Phase 2 PASSPORT Study Was Not Met
12/3/2019 8:40:57 AM
Biogen Announces Positive Phase 2 Study Results For Cutaneous Lupus Erythematosus And Systemic Lupus Erythematosus
11/22/2019 7:33:39 AM
Biogen Announces Detailed Results From Phase 3 EVOLVE-MS-2 Study
11/12/2019 7:02:09 AM
Alkermes Receives $150 Mln Milestone Payment From Biogen Triggered By Recent FDA Approval Of VUMERITY
11/6/2019 7:43:50 AM
Biogen Enter New Deal With Samsung Bioepis To Expand Biosimilars Portfolio
10/30/2019 7:31:19 AM
Biogen And Alkermes Announce FDA Approval Of VUMERITY For Multiple Sclerosis
10/22/2019 7:06:20 AM
Biogen Q3 EPS $8.39; Non-GAAP EPS $9.17
10/22/2019 6:37:26 AM
Biogen Plans To Submit BLA For Aducanumab In Early 2020
10/22/2019 6:36:02 AM
Biogen Plans To Pursue Regulatory Approval For Aducanumab
10/3/2019 8:01:34 AM
Biogen Canada Announce Positive Results From The NURTURE Study
10/1/2019 8:14:12 AM
Biogen: Michael Ehlers, EVP, Research And Development, To Leave